Abstract
Pathophysiology of postpartum depression (PPD) has been associated with many factors, such as neuroendocrine, neuroinflammation and neurotransmitter changes. Fish oil (FO) improves PPD both in humans and animals. However, little is known with regards to its pharmacology on a PPD-like rat model. Hence, the current study aimed at investigating the effects of FO on a PPD-like rat model. Female rats were induced with PPD-like symptoms and then randomly divided into six groups (n = 6) for two experimental protocols. Protocol 1 consisted of PPD-like rats (2 mL distilled water), PPD-like + FO (9 g/kg/d) and PPD-like + Fluoxetine (FLX) (15 mg/kg/d) groups of rats, whereas Protocol 2 consisted of PPD-like rats (2 mL distilled water) + PCPA (p-chlorophenylalanine) 150 mg/kg, PPD-like + FO (9 g/kg/d) + PCPA 150 mg/kg and PPD-like + FLX (15 mg/d) + PCPA 150 mg/kg groups of rats, respectively. All treatments were administered orally for 10 days postpartum, except PCPA, which was given intraperitoneally. Prior to euthanasia, the antidepressant-like effect of the FO was evaluated using the forced swimming test (FST) and open field test (OFT) on day 10 postpartum. Biochemical analysis of serotonin, serotonin metabolite and serotonin turnover from their prefrontal cortex and hippocampus were also measured. The results showed that FO decreased immobility time and increased swimming time significantly, but not climbing time in FST. Further, it also decreased serotonin metabolite and turnover significantly in the hippocampus of the PPD-like rats. In contrast, administration with PCPA reversed all the outcomes. The antidepressant-like effects of FO were found to be similar with that of FLX. Thus, it can be concluded that FO exerts its antidepressant-like effects in PPD-like rats through modulation of serotonergic system.
Highlights
Postpartum depression (PPD) a familiar problem associated with about 10%–20% of women after child delivery [1]
The findings from this study showed that the antidepressant-like effects of Fish oil (FO) after 10 days of supplementation to postpartum depression (PPD)-like rats was influenced by its ability to regulate the level of serotonin in their brain, as treating the PPD-like rats with a PCPA inhibitor, tryptophan hydroxylase, an enzyme responsible for producing serotonin, successfully reversed the effects of the FO on the PPD-like rats
The forced swimming test (FST) conducted in this study showed that supplementation with FO reduces the immobility time and increases the swimming time of the PPD-like rats, decreasing their climbing time
Summary
Postpartum depression (PPD) a familiar problem associated with about 10%–20% of women after child delivery [1]. It has been reported that sudden decrease of ovarian hormones after child delivery and low level of omega-3 fatty acid in postpartum mothers play a contributory role in the development of PPD [5]. The available anti-depressants in the market work by increasing the levels of 5HT at the synaptic junction, which is achieved by inhibiting serotonin transporter (SERT) at synaptic junction. This inhibits the reuptake of 5HT back into the neurons
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have